| Year |
Citation |
Score |
| 2024 |
Chandran V, Gladman DD, Mease PJ, Eder L, Pennington SR, FitzGerald O, Ritchlin C, Webster DE, de Vlam K, Liao W. GRAPPA 2023 Collaborative Research Network Meeting. The Journal of Rheumatology. PMID 39009385 DOI: 10.3899/jrheum.2024-0436 |
0.587 |
|
| 2024 |
Chandran V, Bessette L, Thorne C, Sheriff M, Rahman P, Gladman DD, Anwar S, Jelley J, Gaudreau AJ, Chohan M, Sampalis JS. Use of Apremilast to Achieve Psoriatic Arthritis Treatment Goals and Satisfaction at 1 Year in the Canadian Real-World APPRAISE Study. Rheumatology and Therapy. 11: 443-455. PMID 38416391 DOI: 10.1007/s40744-024-00641-w |
0.444 |
|
| 2024 |
Gladman DD, Chandran V, Rosen CF, Rohekar S, Boyd T, Eder L, Rahman P, Dutz J, Chan J, Haydey RP, Barac S, Laliberté MC, Girard T, Fournier PA, Sutton M, et al. Residual Disease Activity In Canadian Patients With Psoriatic Arthritis (PsA) Treated With Advanced Therapies: Results From A Multi-Registry Analysis (UNISON-PsA). The Journal of Rheumatology. PMID 38359937 DOI: 10.3899/jrheum.2023-0716 |
0.64 |
|
| 2024 |
Koussiouris J, Looby N, Kotlyar M, Kulasingam V, Jurisica I, Chandran V. Classifying patients with psoriatic arthritis according to their disease activity status using serum metabolites and machine learning. Metabolomics : Official Journal of the Metabolomic Society. 20: 17. PMID 38267619 DOI: 10.1007/s11306-023-02079-7 |
0.364 |
|
| 2023 |
Grant C, Perez-Chada L, Haberman RH, Webster D, FitzGerald O, Ritchlin C, Chandran V, Rosen CF, Weber B, Garshick M, Eder L, Reddy SM, Ogdie A, Scher JU, Merola JF. Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) 2021 Annual Meeting Proceedings. Journal of Psoriasis and Psoriatic Arthritis. 8: 179-183. PMID 39301469 DOI: 10.1177/24755303231195967 |
0.543 |
|
| 2023 |
Chandran V, Malkov VA, Ito KL, Liu Y, Vestergaard L, Yoon OK, Liu J, Trivedi M, Hertz A, Gladman D. Pharmacodynamic effects of filgotinib treatment driving clinical improvement in patients with active psoriatic arthritis enrolled in the EQUATOR trial. Rmd Open. 9. PMID 37945284 DOI: 10.1136/rmdopen-2023-003550 |
0.445 |
|
| 2023 |
Choksi H, Li S, Looby N, Kotlyar M, Jurisica I, Kulasingam V, Chandran V. Identifying Serum Metabolomic Markers Associated with Skin Disease Activity in Patients with Psoriatic Arthritis. International Journal of Molecular Sciences. 24. PMID 37894979 DOI: 10.3390/ijms242015299 |
0.303 |
|
| 2023 |
Dand N, Stuart PE, Bowes J, Ellinghaus D, Nititham J, Saklatvala JR, Teder-Laving M, Thomas LF, Traks T, Uebe S, Assmann G, Baudry D, Behrens F, Billi AC, Brown MA, ... ... Chandran V, et al. GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets. Medrxiv : the Preprint Server For Health Sciences. PMID 37873414 DOI: 10.1101/2023.10.04.23296543 |
0.387 |
|
| 2023 |
Colaco K, Lee KA, Akhtari S, Winer R, Chandran V, Harvey P, Cook RJ, Piguet V, Gladman DD, Eder L. Derivation and Internal Validation of a Disease-specific Cardiovascular Risk Prediction Model for Patients with Psoriatic Arthritis and Psoriasis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 37691498 DOI: 10.1002/art.42694 |
0.609 |
|
| 2023 |
Koussiouris J, Chandran V. Autoantibodies in psoriatic disease. Advances in Clinical Chemistry. 115: 135-174. PMID 37673519 DOI: 10.1016/bs.acc.2023.03.006 |
0.329 |
|
| 2023 |
Pirouzmand N, Pereira D, Sutton M, Mathew AJ, Chandran V, Gladman DD. Psoriatic Arthritis And Covid-19 - Patient Perspectives In A Large Psoriatic Arthritis Cohort. The Journal of Rheumatology. PMID 37657794 DOI: 10.3899/jrheum.2022-1265 |
0.449 |
|
| 2023 |
Eder L, Lee KA, Chandran V, Widdifield J, Drucker AM, Ritchlin C, Rosen CF, Cook RJ, Gladman DD. Derivation of a multivariable psoriatic arthritis risk estimation tool (PRESTO): a step towards prevention. Arthritis & Rheumatology (Hoboken, N.J.). PMID 37555242 DOI: 10.1002/art.42661 |
0.62 |
|
| 2023 |
Mease PJ, Nash P, Grieb S, Chandran V. Impact of COVID-19 on Patients With Psoriasis or Psoriatic Arthritis. The Journal of Rheumatology. PMID 37527863 DOI: 10.3899/jrheum.2023-0521 |
0.305 |
|
| 2023 |
Ng BCK, Jadon D, Behrens F, de Wit M, FitzGerald O, Gladman DD, Mease PJ, O'Sullivan D, Pennington SR, Schett G, Chandran V, de Vlam K. Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting. The Journal of Rheumatology. PMID 37527862 DOI: 10.3899/jrheum.2023-0534 |
0.376 |
|
| 2023 |
Ng BCK, Jadon D, Adebajo A, Ayan G, Callis Duffin K, Chandran V, Coates LC, D'Agostino MA, de Vlam K, Deodhar A, Eder L, Garg A, Gladman DD, Goel N, Gottlieb AB, et al. Proceedings of the GRAPPA 2022 Executive Retreat. The Journal of Rheumatology. PMID 37527861 DOI: 10.3899/jrheum.2023-0537 |
0.565 |
|
| 2023 |
Rida MA, Lee KA, Chandran V, Cook RJ, Gladman DD. Persistence of Biologics in the Treatment of Psoriatic Arthritis (Psa): Data From a Large Hospital Based Longitudinal Cohort. Arthritis Care & Research. PMID 36913183 DOI: 10.1002/acr.25112 |
0.366 |
|
| 2023 |
Nazri JM, Oikonomopoulou K, de Araujo ED, Kraskouskaya D, Gunning PT, Chandran V. Histone deacetylase inhibitors as a potential new treatment for psoriatic disease and other inflammatory conditions. Critical Reviews in Clinical Laboratory Sciences. 1-21. PMID 36846924 DOI: 10.1080/10408363.2023.2177251 |
0.313 |
|
| 2022 |
Kwok TSH, Sutton M, Cook RJ, Pereira D, Chandran V, Gladman DD. Musculoskeletal Surgery in Psoriatic Arthritis: Prevalence and Risk Factors. The Journal of Rheumatology. PMID 36379576 DOI: 10.3899/jrheum.220908 |
0.354 |
|
| 2022 |
Kwok TSH, Sutton M, Pereira D, Cook RJ, Chandran V, Haroon N, Inman RD, Gladman DD. Isolated axial disease in psoriatic arthritis and ankylosing spondylitis with psoriasis. Annals of the Rheumatic Diseases. PMID 35973805 DOI: 10.1136/ard-2022-222537 |
0.428 |
|
| 2022 |
Park S, Silverberg OM, Moez E, Chandran V, Gladman DD. Investigation into the wait time for consultation in the psoriatic arthritis program. Clinical Rheumatology. PMID 35869318 DOI: 10.1007/s10067-022-06288-8 |
0.472 |
|
| 2022 |
Mathew AJ, Sutton M, Pereira D, Gladman DD, Chandran V. Effectiveness of Disease Modifying Anti-Rheumatic Drugs for Enthesitis in a Prospective Longitudinal Psoriatic Arthritis Cohort. The Journal of Rheumatology. PMID 35649547 DOI: 10.3899/jrheum.211231 |
0.392 |
|
| 2022 |
Colaço K, Lee KA, Akhtari S, Winer R, Welsh P, Sattar N, McInnes IB, Chandran V, Harvey P, Cook RJ, Gladman DD, Piguet V, Eder L. Association of Cardiac Biomarkers with Cardiovascular Outcomes in Patients with Psoriatic Arthritis and Psoriasis: A Longitudinal Cohort Study. Arthritis & Rheumatology (Hoboken, N.J.). PMID 35261189 DOI: 10.1002/art.42079 |
0.61 |
|
| 2022 |
Eder L, Li Q, Rahmati S, Rahman P, Jurisica I, Chandran V. Defining Imaging Sub-phenotypes of Psoriatic Arthritis: Integrative Analysis of Imaging Data and Gene Expression in a PsA Patient Cohort. Rheumatology (Oxford, England). PMID 35157043 DOI: 10.1093/rheumatology/keac078 |
0.507 |
|
| 2022 |
Damian AC, Colaco K, Rohekar S, Boyd T, Chandran V, Gladman DD, Cook R, Eder L. The incidence and risk factors for venous thromboembolic events in patients with psoriasis and psoriatic arthritis. Seminars in Arthritis and Rheumatism. 53: 151950. PMID 35078035 DOI: 10.1016/j.semarthrit.2022.151950 |
0.612 |
|
| 2021 |
Poddubnyy D, Baraliakos X, Van den Bosch F, Braun J, Coates LC, Chandran V, Diekhoff T, van Gaalen FA, Gensler LS, Goel N, Gottlieb AB, van der Heijde D, Helliwell PS, Hermann KGA, Jadon D, et al. Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Therapeutic Advances in Musculoskeletal Disease. 13: 1759720X211057975. PMID 34987619 DOI: 10.1177/1759720X211057975 |
0.532 |
|
| 2021 |
Taylor JH, Deo M, Sutton M, Chandran V, Shanmugarajah S, Pereira D, Gladman DD, Rosen CF. Assessment of the Toronto Psoriatic Arthritis Screen 2 as a Screening Tool for Psoriasis. Journal of Cutaneous Medicine and Surgery. 12034754211061085. PMID 34841919 DOI: 10.1177/12034754211061085 |
0.379 |
|
| 2021 |
FitzGerald O, Ogdie A, Chandran V, Coates LC, Kavanaugh A, Tillett W, Leung YY, deWit M, Scher JU, Mease PJ. Psoriatic arthritis. Nature Reviews. Disease Primers. 7: 59. PMID 34385474 DOI: 10.1038/s41572-021-00293-y |
0.32 |
|
| 2021 |
Gladman DD, Ye JY, Chandran V, Lee KA, Cook RJ. Oligoarticular Versus Polyarticular Psoriatic Arthritis: A Longitudinal Study Showing Similar Characteristics. The Journal of Rheumatology. PMID 34334360 DOI: 10.3899/jrheum.210434 |
0.475 |
|
| 2021 |
Koussiouris J, Looby N, Anderson M, Kulasingam V, Chandran V. Metabolomics Studies in Psoriatic Disease: A Review. Metabolites. 11. PMID 34200760 DOI: 10.3390/metabo11060375 |
0.306 |
|
| 2021 |
Looby N, Roszkowska A, Reyes-Garcés N, Yu M, Bączek T, Kulasingam V, Pawliszyn J, Chandran V. Serum metabolic fingerprinting of psoriasis and psoriatic arthritis patients using solid-phase microextraction-liquid chromatography-high-resolution mass spectrometry. Metabolomics : Official Journal of the Metabolomic Society. 17: 59. PMID 34137950 DOI: 10.1007/s11306-021-01805-3 |
0.316 |
|
| 2021 |
Stober C, Jadon DR, Armstrong AW, Chandran V, de Wit M, Helliwell PS, Mease PJ, Ogdie A, O'Sullivan D, Pennington SR, Löve T, Cauli A, van Mens L, Waxman R, Scher JU, et al. Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting. The Journal of Rheumatology. Supplement. 97: 4-9. PMID 34074658 DOI: 10.3899/jrheum.201667 |
0.313 |
|
| 2021 |
Colaco K, Lee KA, Akhtari S, Winer R, Welsh P, Sattar N, McInnes IB, Chandran V, Harvey P, Cook RJ, Gladman DD, Piguet V, Eder L. Targeted metabolomic profiling and prediction of cardiovascular events: a prospective study of patients with psoriatic arthritis and psoriasis. Annals of the Rheumatic Diseases. PMID 34049856 DOI: 10.1136/annrheumdis-2021-220168 |
0.611 |
|
| 2021 |
Damian AC, Colaco K, Rohekar S, Boyd T, Chandran V, Gladman DD, Cook R, Eder L. The incidence and risk factors for venous thromboembolic events in patients with psoriasis and psoriatic arthritis. Seminars in Arthritis and Rheumatism. 51: 547-552. PMID 33895651 DOI: 10.1016/j.semarthrit.2021.04.008 |
0.606 |
|
| 2021 |
Feld J, Ye JY, Chandran V, Inman RD, Haroon N, Cook R, Gladman DD. Axial Disease in Psoriatic arthritis: The presence and progression of unilateral grade 2 sacroiliitis in a psoriatic arthritis cohort. Seminars in Arthritis and Rheumatism. 51: 464-468. PMID 33774593 DOI: 10.1016/j.semarthrit.2021.03.007 |
0.485 |
|
| 2021 |
Rahmati S, Li Q, Rahman P, Chandran V. Insights into the pathogenesis of psoriatic arthritis from genetic studies. Seminars in Immunopathology. PMID 33712923 DOI: 10.1007/s00281-021-00843-2 |
0.315 |
|
| 2021 |
Coates LC, Pillai SG, Tahir H, Valter I, Chandran V, Kameda H, Okada M, Kerr L, Alves D, Park SY, Adams DH, Gallo G, Hufford MM, Hojnik M, Mease PJ, et al. Withdrawing Ixekizumab in Patients with Psoriatic Arthritis who Achieved Minimal Disease Activity: Results from a Randomized, Double-Blind Withdrawal Study. Arthritis & Rheumatology (Hoboken, N.J.). PMID 33682378 DOI: 10.1002/art.41716 |
0.327 |
|
| 2021 |
Wong A, Ye JY, Cook RJ, Gladman DD, Chandran V. Depression and Anxiety Reduce the Probability of Achieving a State of Sustained Minimal Disease Activity in Patients with Psoriatic Arthritis. Arthritis Care & Research. PMID 33662181 DOI: 10.1002/acr.24593 |
0.421 |
|
| 2021 |
Perez-Chada LM, Haberman RH, Chandran V, Rosen CF, Ritchlin C, Eder L, Mease P, Reddy S, Ogdie A, Merola JF, Scher JU. Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: results from a Delphi consensus study. Nature Reviews. Rheumatology. PMID 33589818 DOI: 10.1038/s41584-021-00578-2 |
0.53 |
|
| 2021 |
Stober C, Jadon DR, Armstrong AW, Chandran V, de Wit M, Helliwell PS, Mease P, Ogdie A, O'Sullivan D, Pennington SR, Löve T, Cauli A, van Mens L, Waxman R, Scher JU, et al. Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting. The Journal of Rheumatology. PMID 33589562 DOI: 10.3899/jrheum.201667 |
0.313 |
|
| 2021 |
Koppikar S, Colaco K, Harvey P, Akhtari S, Chandran V, Gladman DD, Cook R, Eder L. Incidence of and Risk Factors for Heart Failure in Patients with Psoriatic Disease - A Cohort Study. Arthritis Care & Research. PMID 33571391 DOI: 10.1002/acr.24578 |
0.579 |
|
| 2020 |
Polachek A, Muntyanu A, Lee KA, Ye JY, Chandran V, Cook RJ, Gladman DD. Malignancy in psoriatic disease: Results from prospective longitudinal cohorts. Seminars in Arthritis and Rheumatism. 51: 144-149. PMID 33383290 DOI: 10.1016/j.semarthrit.2020.12.008 |
0.471 |
|
| 2020 |
Kwok TSH, Sutton M, Yang Ye J, Pereira D, Chandran V, Gladman DD. Prevalence and factors associated with osteoporosis and bone mineral density testing in psoriatic arthritis. Arthritis Care & Research. PMID 33326187 DOI: 10.1002/acr.24538 |
0.359 |
|
| 2020 |
Rahmati S, O'Rielly DD, Li Q, Codner D, Dohey A, Jenkins K, Jurisica I, Gladman DD, Chandran V, Rahman P. Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritis. Scientific Reports. 10: 21703. PMID 33303908 DOI: 10.1038/s41598-020-78866-2 |
0.386 |
|
| 2020 |
Chandran V. It Is High Time That We Define Axial Psoriatic Arthritis. The Journal of Rheumatology. 47: 1301-1302. PMID 32873661 DOI: 10.3899/Jrheum.200103 |
0.469 |
|
| 2020 |
Elalouf O, Muntyanu A, Polachek A, Pereira D, Ye JY, Lee KA, Chandran V, Cook RJ, Gladman DD. Mortality in psoriatic arthritis: Risk, causes of death, predictors for death. Seminars in Arthritis and Rheumatism. 50: 571-575. PMID 32454305 DOI: 10.1016/J.Semarthrit.2020.04.001 |
0.437 |
|
| 2020 |
Chandran V. Pathway to biomarker discovery in psoriatic arthritis. Expert Review of Clinical Immunology. PMID 32250175 DOI: 10.1080/1744666X.2020.1752667 |
0.426 |
|
| 2020 |
Li Q, Chandran V, Tsoi L, O'Rielly D, Nair RP, Gladman D, Elder JT, Rahman P. Quantifying Differences in Heritability among Psoriatic Arthritis (PsA), Cutaneous Psoriasis (PsC) and Psoriasis vulgaris (PsV). Scientific Reports. 10: 4925. PMID 32188927 DOI: 10.1038/S41598-020-61981-5 |
0.554 |
|
| 2020 |
Rahmati S, Tsoi L, O'Rielly D, Chandran V, Rahman P. Complexities in Genetics of Psoriatic Arthritis. Current Rheumatology Reports. 22: 10. PMID 32166449 DOI: 10.1007/S11926-020-0886-X |
0.348 |
|
| 2020 |
Alharbi S, Ye JY, Lee KA, Chandran V, Cook RJ, Gladman DD. Remission in psoriatic arthritis: Definition and predictors. Seminars in Arthritis and Rheumatism. PMID 32145969 DOI: 10.1016/J.Semarthrit.2020.01.012 |
0.534 |
|
| 2020 |
Coates LC, Baraliakos X, Blanco FJ, Blanco-Morales E, Braun J, Chandran V, Luiz Fernandez-Sueiro J, FitzGerald O, Gallagher P, Gladman DD, Gubar E, Korotaeva T, Loginova E, Lubrano E, Mulero J, et al. The phenotype of axial spondyloarthritis: is it dependent on HLA-B27 status? Arthritis Care & Research. PMID 32100954 DOI: 10.1002/Acr.24174 |
0.4 |
|
| 2020 |
Abji F, Ye JY, Cook RJ, Oikonomopoulou K, Chandran V. The association between synovial fluid serine proteinase activity and response to intra-articular corticosteroid injection in psoriatic arthritis. Clinical Rheumatology. PMID 32100195 DOI: 10.1007/S10067-020-05003-9 |
0.369 |
|
| 2020 |
Chandran V, van der Heijde D, Fleischmann RM, Lespessailles E, Helliwell PS, Kameda H, Burgos-Vargas R, Erickson JS, Rathmann SS, Sprabery AT, Birt JA, Shuler CL, Gallo G. Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1). Rheumatology (Oxford, England). PMID 32031665 DOI: 10.1093/Rheumatology/Kez684 |
0.352 |
|
| 2020 |
Elmamoun M, Eraso M, Anderson M, Maharaj A, Coates L, Chandran V, Abogamal A, Adebajo AO, Ajibade A, Ayanlowo O, Azevedo V, Bautista-Molano W, Carneiro S, Goldenstein-Schainberg C, et al. International league of associations for rheumatology recommendations for the management of psoriatic arthritis in resource-poor settings. Clinical Rheumatology. PMID 31950441 DOI: 10.1007/S10067-020-04934-7 |
0.36 |
|
| 2020 |
Gladman DD, Jiang W, Hertz A, Malkov V, Yoon OK, Trivedi M, Alani M, Vestergaard L, Besuyen R, Galien R, Mirza AM, Chandran V. Op0224 Filgotinib Treatment Leads To Rapid And Sustained Reductions In Inflammatory Biomarkers In Patients With Moderate To Severe Psoriatic Arthritis Annals of the Rheumatic Diseases. 79: 140-140. DOI: 10.1136/Annrheumdis-2020-Eular.4927 |
0.382 |
|
| 2020 |
Poddubnyy D, Mease PJ, Bosch FVd, Braun J, Gottlieb A, Coates LC, Chandran V, Helliwell P, Jadon D, Sieper J, Heijde DVd, Gladman DD. Ab0824 Which Parameters Are Relevant In The Identifying Axial Involvement In Psoriatic Arthritis? – Results Of A Survey Among Asas And Grappa Members Annals of the Rheumatic Diseases. 79: 1715-1716. DOI: 10.1136/Annrheumdis-2020-Eular.2719 |
0.37 |
|
| 2020 |
Eder L, Li Q, Rahmati S, Eshed I, Rahman P, Jurisica I, Chandran V. Sat0359 The Association Between Imaging Sub-Phenotypes Of Psoriatic Arthritis And Gene Expression Profiles Annals of the Rheumatic Diseases. 79: 1126-1127. DOI: 10.1136/Annrheumdis-2020-Eular.1709 |
0.564 |
|
| 2020 |
Coates LC, Pillai SG, Zhang L, Adams D, Kerr L, Hojnik M, Gallo G, Valter I, Tahir H, Chandran V, Mease P, Kavanaugh A. P261 Continuing versus withdrawing ixekizumab in patients with PsA who achieved sustained minimal disease activity: results from the SPIRIT-P3 study Rheumatology. 59. DOI: 10.1093/Rheumatology/Keaa111.254 |
0.362 |
|
| 2019 |
Pakchotanon R, Ye Y, Cook RJ, Chandran V, Gladman DD. Liver Abnormalities in Patients with Psoriatic Arthritis. The Journal of Rheumatology. PMID 31615918 DOI: 10.3899/Jrheum.181312 |
0.505 |
|
| 2019 |
Feld J, Ye JY, Chandran V, Inman RD, Haroon N, Cook R, Gladman DD. Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis? Rheumatology (Oxford, England). PMID 31593590 DOI: 10.1093/Rheumatology/Kez457 |
0.571 |
|
| 2019 |
Chandran V, Cook RJ, Gladman DD. Response to: 'Can biomarkers differentiate psoriatic arthritis from osteoarthritis?' by Tian . Annals of the Rheumatic Diseases. PMID 31272941 DOI: 10.1136/Annrheumdis-2019-215762 |
0.496 |
|
| 2019 |
Perruccio AV, Got M, Li S, Ye Y, Gladman DD, Chandran V. Treating Psoriatic Arthritis to Target: Defining Psoriatic Arthritis Disease Activity Score (PASDAS) That Reflects State Of Minimal Disease Activity (MDA). The Journal of Rheumatology. PMID 31203221 DOI: 10.3899/Jrheum.181472 |
0.506 |
|
| 2019 |
Fei JZ, Perruccio AV, Ye JY, Gladman DD, Chandran V. The relationship between patient acceptable symptom state and disease activity in patients with psoriatic arthritis. Rheumatology (Oxford, England). PMID 31199486 DOI: 10.1093/Rheumatology/Kez202 |
0.533 |
|
| 2019 |
Sobchak C, Akhtari S, Harvey P, Gladman D, Chandran V, Cook R, Eder L. The value of carotid ultrasound in cardiovascular risk stratification in patients with psoriatic disease. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31165591 DOI: 10.1002/Art.40925 |
0.641 |
|
| 2019 |
Jadon DR, Chandran V, Ogdie A, Pennington SR, Stober C, Gladman DD, de Wit M, O'Sullivan D, Mease P, Armstrong AW, Callis Duffin K, Magee C, Helliwell P, Ritchlin CT, FitzGerald O. Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting. The Journal of Rheumatology. Supplement. 95: 11-19. PMID 31154399 DOI: 10.3899/Jrheum.190118 |
0.462 |
|
| 2019 |
Johnson K, Ye JY, Chandran V, Gladman DD. A novel role for the psoriatic arhtirtis impact of disease (PsAID) questionnaire. Seminars in Arthritis and Rheumatism. PMID 31101369 DOI: 10.1016/J.Semarthrit.2019.04.001 |
0.542 |
|
| 2019 |
Patrick MT, Stuart PE, Raja K, Chi S, He Z, Voorhees JJ, Tejasvi T, Gudjonsson JE, Kahlenberg JM, Chandran V, Rahman P, Gladman DD, Nair RP, Elder JT, Tsoi LC. Integrative Approach to Reveal Cell Type Specificity and Gene Candidates for Psoriatic Arthritis Outside the MHC. Frontiers in Genetics. 10: 304. PMID 31031798 DOI: 10.3389/Fgene.2019.00304 |
0.476 |
|
| 2019 |
Chandran V, Abji F, Perruccio AV, Gandhi R, Li S, Cook RJ, Gladman DD. Serum-based soluble markers differentiate psoriatic arthritis from osteoarthritis. Annals of the Rheumatic Diseases. PMID 30910989 DOI: 10.1136/Annrheumdis-2018-214737 |
0.478 |
|
| 2019 |
Perruccio AV, Got M, Li S, Ye Y, Gladman DD, Chandran V. The development of a modified Psoriatic Arthritis Disease Activity Score (mPASDAS) using SF-12 as a measure of quality of life. Arthritis Care & Research. PMID 30875460 DOI: 10.1002/Acr.23876 |
0.53 |
|
| 2019 |
Pollock RA, Zaman L, Chandran V, Gladman DD. Epigenome-wide analysis of sperm cells identifies IL22 as a possible germ line risk locus for psoriatic arthritis. Plos One. 14: e0212043. PMID 30779748 DOI: 10.1371/Journal.Pone.0212043 |
0.509 |
|
| 2019 |
Polachek A, Cook R, Chandran V, Gladman DD, Eder L. Correction to: The association between sonographic enthesitis and radiographic damage in psoriatic arthritis. Arthritis Research & Therapy. 21: 20. PMID 30642391 DOI: 10.1186/S13075-019-1814-1 |
0.582 |
|
| 2019 |
Chandran V. Advanced therapies for inflammatory rheumatic diseases in resource-poor settings Indian Journal of Rheumatology. 14: 7. DOI: 10.4103/0973-3698.254191 |
0.301 |
|
| 2019 |
Machhar R, Oke S, Ye J, Abji F, Chandran V. Op0301 C-X-C Motif Chemokine 10 (Cxcl10) Is A Potential Biomarker Of Disease Activity In Psoriatic Arthritis (Psa) Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.7435 |
0.317 |
|
| 2019 |
Harbi SA, Lee K, Chandran V, Cook R, Gladman DD. Sat0360 Remission In Psoriatic Arthritis: Definition And Predictors Annals of the Rheumatic Diseases. 78: 1260-1261. DOI: 10.1136/Annrheumdis-2019-Eular.7248 |
0.487 |
|
| 2019 |
Pollock R, Machhar R, Chandran V, Gladman DD. Op0203 Characterizing The Epigenomic Landscape Of Psoriasis Patients Destined To Develop Psoriatic Arthritis Annals of the Rheumatic Diseases. 78: 177-178. DOI: 10.1136/Annrheumdis-2019-Eular.4185 |
0.382 |
|
| 2019 |
Quan L, Chandran V, Tsoi L, Nair R, Gladman DD, Elder JT, Rahman P. Ab0020B Quantifying Differences In Heritability Among Psoriatic Arthritis (Psa), Cutaneous Psoriasis (Psc) And Psoriasis Vulgaris (Psv) Annals of the Rheumatic Diseases. 78: 1476-1477. DOI: 10.1136/Annrheumdis-2019-Eular.3317 |
0.375 |
|
| 2018 |
Polachek A, Polachek Shlomi I, Spitzer K, Pereira D, Ye JY, Chandran V, Laskin CA, Gladman DD. Outcome of pregnancy in women with psoriatic arthritis compared to healthy controls. Clinical Rheumatology. PMID 30535992 DOI: 10.1007/S10067-018-4385-7 |
0.46 |
|
| 2018 |
Feld J, Chandran V, Gladman DD. What Is Axial Psoriatic Arthritis? The Journal of Rheumatology. 45: 1611-1613. PMID 30504477 DOI: 10.3899/Jrheum.180802 |
0.567 |
|
| 2018 |
Wakhlu A, Chandran V, Phumethum V, Shen H, Cook RJ, Gladman D. Comparison Between INSPIRE and Domjan method for measuring lumbar lateral flexion in patients of psoriatic arthritis (PsA) and correlation with radiographic damage. Clinical Rheumatology. PMID 30498874 DOI: 10.1007/S10067-018-4375-9 |
0.481 |
|
| 2018 |
Polachek A, Li S, Polachek IS, Chandran V, Gladman D. Corrigendum to "Psoriatic arthritis disease activity during pregnancy and the first-year postpartum" [Semin. Arthritis Rheum. 46 (6) (2017) 740-745]. Seminars in Arthritis and Rheumatism. PMID 30477737 DOI: 10.1016/J.Semarthrit.2018.11.001 |
0.489 |
|
| 2018 |
Elmamoun M, Leung YY, O'Sullivan D, Steinkoenig I, Chandran V, Gladman DD, FitzGerald OM, Orbai AM, Eder L. Using Acute-phase Reactants to Inform the Development of Instruments for the Updated Psoriatic Arthritis Core Outcome Measurement Set. The Journal of Rheumatology. PMID 30385708 DOI: 10.3899/Jrheum.180195 |
0.612 |
|
| 2018 |
Patrick MT, Stuart PE, Raja K, Gudjonsson JE, Tejasvi T, Yang J, Chandran V, Das S, Callis-Duffin K, Ellinghaus E, Enerbäck C, Esko T, Franke A, Kang HM, Krueger GG, et al. Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients. Nature Communications. 9: 4178. PMID 30301895 DOI: 10.1038/S41467-018-06672-6 |
0.544 |
|
| 2018 |
Polachek A, Al-Johani R, Li S, Ye JY, Chandran V, Gladman D. Late onset psoriatic arthritis in a longitudinal cohort: Disease presentation, activity over time and prognosis. Seminars in Arthritis and Rheumatism. PMID 30243758 DOI: 10.1016/J.Semarthrit.2018.08.005 |
0.559 |
|
| 2018 |
Yap KS, Ye JY, Li S, Gladman DD, Chandran V. Back pain in psoriatic arthritis: defining prevalence, characteristics and performance of inflammatory back pain criteria in psoriatic arthritis. Annals of the Rheumatic Diseases. PMID 30077991 DOI: 10.1136/Annrheumdis-2018-213334 |
0.47 |
|
| 2018 |
Zhou W, Chandran V, Cook R, Gladman DD, Eder L. The association between occupational-related mechanical stress and radiographic damage in psoriatic arthritis. Seminars in Arthritis and Rheumatism. PMID 30057322 DOI: 10.1016/J.Semarthrit.2018.06.001 |
0.654 |
|
| 2018 |
Jadon DR, Chandran V, Stober C, Ogdie A, Armstrong AW, Callis Duffin K, Gladman DD, Helliwell PS, O'Sullivan D, de Wit M, FitzGerald O, Ritchlin CT. Proceedings of the 2017 GRAPPA Collaborative Research Network Meeting. The Journal of Rheumatology. Supplement. 94: 54-61. PMID 29858357 DOI: 10.3899/Jrheum.180141 |
0.488 |
|
| 2018 |
Elalouf O, Chandran V. Novel Therapeutics in Psoriatic Arthritis. What Is in the Pipeline? Current Rheumatology Reports. 20: 36. PMID 29846825 DOI: 10.1007/S11926-018-0746-0 |
0.33 |
|
| 2018 |
Feld J, Chandran V, Haroon N, Inman R, Gladman D. Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison. Nature Reviews. Rheumatology. PMID 29752461 DOI: 10.1038/S41584-018-0006-8 |
0.579 |
|
| 2018 |
Chandran V, Stecher L, Farewell V, Gladman DD. Patterns of peripheral joint involvement in psoriatic arthritis-Symmetric, ray and/or row? Seminars in Arthritis and Rheumatism. PMID 29724452 DOI: 10.1016/J.Semarthrit.2018.03.002 |
0.463 |
|
| 2018 |
Elmamoun M, Chandran V. Role of Methotrexate in the Management of Psoriatic Arthritis. Drugs. PMID 29616495 DOI: 10.1007/S40265-018-0898-2 |
0.362 |
|
| 2018 |
Eder L, Harvey P, Chandran V, Rosen CF, Dutz J, Elder JT, Rahman P, Ritchlin CT, Rohekar S, Hayday R, Barac S, Feld J, Zisman D, Gladman DD. Gaps in Diagnosis and Treatment of Cardiovascular Risk Factors in Patients with Psoriatic Disease: An International Multicenter Study. The Journal of Rheumatology. PMID 29419462 DOI: 10.3899/Jrheum.170379 |
0.667 |
|
| 2018 |
Oikonomopoulou K, Diamandis EP, Hollenberg MD, Chandran V. Proteinases and their receptors in inflammatory arthritis: an overview. Nature Reviews. Rheumatology. PMID 29416136 DOI: 10.1038/Nrrheum.2018.17 |
0.334 |
|
| 2018 |
Mahendran SM, Chandran V. Exploring the Psoriatic Arthritis Proteome in Search of Novel Biomarkers. Proteomes. 6. PMID 29364831 DOI: 10.3390/Proteomes6010005 |
0.401 |
|
| 2018 |
Polachek A, Cook R, Chandran V, Abji F, Gladman D, Eder L. The Association between HLA Genetic Susceptibility Markers and Sonographic Enthesitis in Psoriatic Arthritis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 29361203 DOI: 10.1002/Art.40423 |
0.638 |
|
| 2018 |
Johnson K, Ye J, Chandran V, Gladman D. THU0301 A novel role for the psoriatic arthritis impact of disease questionnaire (PSAID) Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2018-Eular.6751 |
0.502 |
|
| 2018 |
Patrick M, Stuart P, Raja K, Yang J, Zawistowski M, Voorhees J, Tejasvi T, Gudjonsson J, Chandran V, Rahman P, Nair R, Gladman D, Elder J, Tsoi L. 746 Challenges and opportunities for integrating genetics and health records in risk assessment for psoriasis subtypes Journal of Investigative Dermatology. 138: S127. DOI: 10.1016/J.Jid.2018.03.756 |
0.416 |
|
| 2018 |
Puig L, Korman N, Greggio C, Cirulli J, Teng L, Chandran V, Khraishi M, Meht N. Hemoglobin A1c and weight changes with apremilast in patients with psoriasis and psoriatic arthritis: Pooled laboratory analysis of the phase 3 ESTEEM and PALACE trials Journal of the American Academy of Dermatology. 79. DOI: 10.1016/J.Jaad.2018.05.625 |
0.312 |
|
| 2017 |
Mahendran SM, Oikonomopoulou K, Diamandis EP, Chandran V. Synovial fluid proteomics in the pursuit of arthritis mediators: An evolving field of novel biomarker discovery. Critical Reviews in Clinical Laboratory Sciences. 54: 495-505. PMID 29202618 DOI: 10.1080/10408363.2017.1408561 |
0.37 |
|
| 2017 |
AlJohani R, Polachek A, Ye JY, Chandran V, Gladman DD. Characteristic and Outcome of Psoriatic Arthritis Patients with Hyperuricemia. The Journal of Rheumatology. PMID 29196385 DOI: 10.3899/Jrheum.170384 |
0.528 |
|
| 2017 |
Patel P, Rosen CF, Chandran V, Ye YJ, Gladman DD. Addressing comorbidities in psoriatic disease. Rheumatology International. PMID 29185085 DOI: 10.1007/S00296-017-3895-Y |
0.532 |
|
| 2017 |
Abji F, Pollock RA, Liang K, Chandran V, Gladman DD. Th17 gene expression in psoriatic arthritis synovial fluid and peripheral blood compared to osteoarthritis and cutaneous psoriasis. Clinical and Experimental Rheumatology. PMID 29148410 |
0.397 |
|
| 2017 |
Dand N, Mucha S, Tsoi LC, Mahil SK, Stuart PE, Arnold A, Baurecht H, Burden AD, Duffin KC, Chandran V, Curtis CJ, Das S, Ellinghaus D, Ellinghaus E, Enerback C, et al. Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling. Human Molecular Genetics. PMID 28973304 DOI: 10.1093/Hmg/Ddx328 |
0.441 |
|
| 2017 |
Barber CEH, Mosher DP, Ahluwalia V, Zummer M, Marshall DA, Choquette D, Lacaille D, Bombardier C, Lyddiatt A, Chandran V, Khodyakov D, Dao E, Barnabe C. Development of a Canadian Core Clinical Dataset to Support High-quality Care for Canadian Patients with Rheumatoid Arthritis. The Journal of Rheumatology. PMID 28966205 DOI: 10.3899/Jrheum.170421 |
0.339 |
|
| 2017 |
Polachek A, Cook R, Chandran V, Gladman DD, Eder L. The association between sonographic enthesitis and radiographic damage in psoriatic arthritis. Arthritis Research & Therapy. 19: 189. PMID 28810926 DOI: 10.1186/S13075-017-1399-5 |
0.64 |
|
| 2017 |
Berinstein J, Pollock R, Pellett F, Thavaneswaran A, Chandran V, Gladman DD. Association of variably expressed KIR3dl1 alleles with psoriatic disease. Clinical Rheumatology. PMID 28801811 DOI: 10.1007/S10067-017-3784-5 |
0.504 |
|
| 2017 |
Maldonado-Ficco H, Sheane BJ, Thavaneswaran A, Chandran V, Gladman DD. Magnetic Resonance Imaging in Psoriatic Arthritis: A Descriptive Study of Indications, Features and Effect on Treatment Change. Journal of Clinical Rheumatology : Practical Reports On Rheumatic & Musculoskeletal Diseases. PMID 28700527 DOI: 10.1097/Rhu.0000000000000558 |
0.416 |
|
| 2017 |
Wong ITY, Chandran V, Li S, Gladman DD. Sleep Disturbance in Psoriatic Disease: Prevalence and Associated Factors. The Journal of Rheumatology. PMID 28620064 DOI: 10.3899/Jrheum.161330 |
0.435 |
|
| 2017 |
Gladman DD, Poulin Y, Adams K, Bourcier M, Barac S, Barber K, Chandran V, Dutz J, Flanagan C, Gooderham MJ, Gulliver WP, Ho VC, Hong CH, Karsh J, Khraishi MM, et al. Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice. The Journal of Rheumatology. 44: 519-534. PMID 28604347 DOI: 10.3899/Jrheum.161473 |
0.454 |
|
| 2017 |
Cretu D, Gao L, Liang K, Soosaipillai A, Diamandis EP, Chandran V. Novel serum biomarkers differentiate psoriatic arthritis from psoriasis without psoriatic arthritis. Arthritis Care & Research. PMID 28586166 DOI: 10.1002/Acr.23298 |
0.423 |
|
| 2017 |
Tsoi LC, Stuart PE, Tian C, Gudjonsson JE, Das S, Zawistowski M, Ellinghaus E, Barker JN, Chandran V, Dand N, Duffin KC, Enerbäck C, Esko T, Franke A, Gladman DD, et al. Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants. Nature Communications. 8: 15382. PMID 28537254 DOI: 10.1038/Ncomms15382 |
0.443 |
|
| 2017 |
Jadon DR, Gladman DD, Mease PJ, FitzGerald O, Chandran V, Goel N, Rosen CF, Maksymowych WP, Ritchlin CT, Ogdie A, Coates LC, Cauli A, Soriano ER, Husni ME, Campbell W, et al. Proceedings of the GRAPPA 2016 Retreat. The Journal of Rheumatology. 44: 668-673. PMID 28461522 DOI: 10.3899/Jrheum.170141 |
0.461 |
|
| 2017 |
Eder L, Abji F, Rosen CF, Chandran V, Gladman DD. The Association Between Obesity and Clinical Features of Psoriatic Arthritis: A Case-control Study. The Journal of Rheumatology. PMID 28202737 DOI: 10.3899/Jrheum.160532 |
0.614 |
|
| 2017 |
Polachek A, Li S, Polachek IS, Chandran V, Gladman D. Psoriatic arthritis disease activity during pregnancy and the first-year postpartum. Seminars in Arthritis and Rheumatism. PMID 28196621 DOI: 10.1016/J.Semarthrit.2017.01.002 |
0.509 |
|
| 2017 |
Eder L, Chandran V, Cook R, Gladman DD. The Risk of Developing Diabetes Mellitus in Patients with Psoriatic Arthritis: A Cohort Study. The Journal of Rheumatology. PMID 28148695 DOI: 10.3899/Jrheum.160861 |
0.644 |
|
| 2017 |
Ibrahim A, Gladman DD, Thavaneswaran A, Eder L, Helliwell P, Cook RJ, Chandran V. Radiographic scoring instruments have moderate sensitivity but high specificity for detecting change in axial psoriatic arthritis. Arthritis Care & Research. PMID 28085226 DOI: 10.1002/Acr.23189 |
0.633 |
|
| 2017 |
Fei J, Perruccio A, Ye Y, Gladman D, Chandran V. SAT0481 The relationship between the patient acceptable symptom state (PASS) and disease activity in patients with psoriatic arthritis (PSA) Annals of the Rheumatic Diseases. 76: 957-957. DOI: 10.1136/Annrheumdis-2017-Eular.6186 |
0.548 |
|
| 2016 |
Polachek A, Li S, Chandran V, Gladman D. Clinical enthesitis in a prospective longitudinal psoriatic arthritis cohort: Incidence, prevalence, characteristics and outcome. Arthritis Care & Research. PMID 27998023 DOI: 10.1002/Acr.23174 |
0.51 |
|
| 2016 |
Muntyanu A, Abji F, Liang K, Pollock RA, Chandran V, Gladman DD. Differential gene and protein expression of chemokines and cytokines in synovial fluid of patients with arthritis. Arthritis Research & Therapy. 18: 296. PMID 27964744 DOI: 10.1186/S13075-016-1196-6 |
0.519 |
|
| 2016 |
Maharaj AB, Chandran V. Treatment of psoriatic arthritis with traditional DMARD's and novel therapies: approaches and recommendations. Expert Review of Clinical Immunology. PMID 27826996 DOI: 10.1080/1744666X.2017.1257939 |
0.321 |
|
| 2016 |
Eder L, Polachek A, Rosen CF, Chandran V, Cook R, Gladman DD. The development of PsA in patients with psoriasis is preceded by a period of non-specific musculoskeletal symptoms: A prospective cohort study. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27792862 DOI: 10.1002/Art.39973 |
0.662 |
|
| 2016 |
Eder L, Abji F, Rosen CF, Chandran V, Cook RJ, Gladman DD. The Association of HLA-class I Genes and the Extent of Atherosclerotic Plaques in Patients with Psoriatic Disease. The Journal of Rheumatology. PMID 27585683 DOI: 10.3899/Jrheum.151469 |
0.669 |
|
| 2016 |
Sheane BJ, Thavaneswaran A, Gladman DD, Chandran V. Attainment of Minimal Disease Activity Using Methotrexate in Psoriatic Arthritis. The Journal of Rheumatology. PMID 27422895 DOI: 10.3899/Jrheum.160111 |
0.524 |
|
| 2016 |
Abji F, Pollock RA, Liang K, Chandran V, Gladman DD. C-X-C Motif Chemokine 10 is a Possible Biomarker for the Development of Psoriatic Arthritis among Patients with Psoriasis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27389865 DOI: 10.1002/Art.39800 |
0.489 |
|
| 2016 |
Sharma A, Dhooria A, Aggarwal A, Rathi M, Chandran V. Connective Tissue Disorder-Associated Vasculitis. Current Rheumatology Reports. 18: 31. PMID 27097818 DOI: 10.1007/S11926-016-0584-X |
0.344 |
|
| 2016 |
Touma Z, Thavaneswaran A, Chandran V, Pellett F, Cook RJ, Gladman DD. Clinical and Demographic Characteristics of Erosion-free and Erosion-present Status in Psoriatic Arthritis in a Cohort Study. The Journal of Rheumatology. PMID 27036389 DOI: 10.3899/Jrheum.150466 |
0.576 |
|
| 2016 |
Chandran V, Maharaj AB. Assessing disease activity in psoriasis and psoriatic arthritis: impact on management and therapy. Expert Review of Clinical Immunology. 1-10. PMID 26807494 DOI: 10.1586/1744666X.2016.1146133 |
0.355 |
|
| 2016 |
Haddad A, Li S, Thavaneswaran A, Cook RJ, Chandran V, Gladman DD. The Incidence and Predictors of Infection in Psoriasis and Psoriatic Arthritis: Results from Longitudinal Observational Cohorts. The Journal of Rheumatology. PMID 26773102 DOI: 10.3899/Jrheum.140067 |
0.533 |
|
| 2016 |
Chandran V, Cretu D, Gao L, Liang K, Diamandis E. AB0748 Novel Biomarkers Distinguish Psoriatic Arthritis from Psoriasis Annals of the Rheumatic Diseases. 75: 1160.3-1161. DOI: 10.1136/Annrheumdis-2016-Eular.3697 |
0.412 |
|
| 2016 |
Chandran V, Got M, Li S, Perruccio A, Gladman D. FRI0477 A Modified Version of The Psoriatic Arthritis Disease Activity Score (MPASDAS) Using Sf-12 as A Measure of Quality of Life May Be More Feasible in Clinical Practice Annals of the Rheumatic Diseases. 75: 611.1-611. DOI: 10.1136/Annrheumdis-2016-Eular.3677 |
0.551 |
|
| 2016 |
Chandran V, Perruccio A, Li S, Abji F, Gandhi R, Gladman D. THU0421 Serum-Based Soluble Markers May Differentiate Psoriatic Arthritis from Osteoarthritis Annals of the Rheumatic Diseases. 75: 341.2-342. DOI: 10.1136/Annrheumdis-2016-Eular.3644 |
0.506 |
|
| 2016 |
Eder L, Polachek A, Rosen C, Chandran V, Gladman D. THU0444 Subclinical Ultrasonographic Enthesitis in Patients with Psoriasis Is Associated with Risk Markers for Psoriatic Arthritis Annals of the Rheumatic Diseases. 75: 352.1-352. DOI: 10.1136/Annrheumdis-2016-Eular.1848 |
0.675 |
|
| 2016 |
Eder L, Chandran V, Cook R, Gladman D. THU0424 Treatment with Tnf Alpha Blockers Is Associated with Reduced Progression of Atherosclerotic Plaques in Patients with Psoriatic Disease – A Prospective Study Annals of the Rheumatic Diseases. 75: 343.1-343. DOI: 10.1136/Annrheumdis-2016-Eular.1843 |
0.658 |
|
| 2015 |
Stuart PE, Nair RP, Tsoi LC, Tejasvi T, Das S, Kang HM, Ellinghaus E, Chandran V, Callis-Duffin K, Ike R, Li Y, Wen X, Enerbäck C, Gudjonsson JE, Kõks S, et al. Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture. American Journal of Human Genetics. PMID 26626624 DOI: 10.1016/J.Ajhg.2015.10.019 |
0.477 |
|
| 2015 |
Eder L, Haddad A, Rosen CF, Lee KA, Chandran V, Cook R, Gladman DD. The incidence and risk factors for psoriatic arthritis in patients with psoriasis - a prospective cohort study. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26555117 DOI: 10.1002/Art.39494 |
0.667 |
|
| 2015 |
Eder L, Wu Y, Chandran V, Cook R, Gladman DD. Incidence and predictors for cardiovascular events in patients with psoriatic arthritis. Annals of the Rheumatic Diseases. PMID 26493817 DOI: 10.1136/Annrheumdis-2015-207980 |
0.664 |
|
| 2015 |
Haddad A, Johnson SR, Somaily M, Fazelzad R, Kron AT, Chau C, Chandran V. Psoriatic Arthritis Mutilans: Clinical and Radiographic Criteria. A Systematic Review. The Journal of Rheumatology. PMID 26077409 DOI: 10.3899/Jrheum.141545 |
0.345 |
|
| 2015 |
Pollock RA, Thavaneswaran A, Pellett F, Chandran V, Petronis A, Rahman P, Gladman DD. Further Evidence Supporting a Parent-of-Origin Effect in Psoriatic Disease. Arthritis Care & Research. 67: 1586-90. PMID 26017758 DOI: 10.1002/Acr.22625 |
0.489 |
|
| 2015 |
Kaka H, Ayearst R, Tran M, Touma Z, Bagovich M, Vinik O, Somaily M, Haddad A, Gladman DD, Chandran V. DEVELOPING AN IPAD® APPLICATION FOR DATA COLLECTION IN A RHEUMATOLOGY RESEARCH CLINIC. International Journal of Technology Assessment in Health Care. 31: 99-102. PMID 25991410 DOI: 10.1017/S0266462315000069 |
0.402 |
|
| 2015 |
Tsoi LC, Spain SL, Ellinghaus E, Stuart PE, Capon F, Knight J, Tejasvi T, Kang HM, Allen MH, Lambert S, Stoll SW, Weidinger S, Gudjonsson JE, Koks S, Kingo K, ... ... Chandran V, et al. Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci. Nature Communications. 6: 7001. PMID 25939698 DOI: 10.1038/Ncomms8001 |
0.438 |
|
| 2015 |
Tom BD, Chandran V, Farewell VT, Rosen CF, Gladman DD. Validation of the Toronto Psoriatic Arthritis Screen Version 2 (ToPAS 2). The Journal of Rheumatology. 42: 841-6. PMID 25834198 DOI: 10.3899/Jrheum.140857 |
0.464 |
|
| 2015 |
Maharaj AB, Chandran V. Pancytopenia in a patient with psoriatic arthritis treated with methotrexate and concomitant lithium. The Journal of Rheumatology. 42: 557. PMID 25729049 DOI: 10.3899/Jrheum.141022 |
0.398 |
|
| 2015 |
Rohekar S, Chan J, Tse SM, Haroon N, Chandran V, Bessette L, Mosher D, Flanagan C, Keen KJ, Adams K, Mallinson M, Thorne C, Rahman P, Gladman DD, Inman RD. 2014 Update of the Canadian Rheumatology Association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. Part I: principles of the management of spondyloarthritis in Canada. The Journal of Rheumatology. 42: 654-64. PMID 25684770 DOI: 10.3899/Jrheum.141000 |
0.398 |
|
| 2015 |
Rohekar S, Chan J, Tse SM, Haroon N, Chandran V, Bessette L, Mosher D, Flanagan C, Keen KJ, Adams K, Mallinson M, Thorne C, Rahman P, Gladman DD, Inman RD. 2014 Update of the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Treatment Recommendations for the Management of Spondyloarthritis. Part II: Specific Management Recommendations. The Journal of Rheumatology. 42: 665-81. PMID 25684768 DOI: 10.3899/Jrheum.141001 |
0.402 |
|
| 2015 |
Cretu D, Liang K, Saraon P, Batruch I, Diamandis EP, Chandran V. Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers. Clinical Proteomics. 12: 1. PMID 25678896 DOI: 10.1186/1559-0275-12-1 |
0.387 |
|
| 2015 |
Haddad A, Thavaneswaran A, Ruiz-Arruza I, Pellett F, Chandran V, Cook RJ, Gladman DD. Minimal disease activity and anti-tumor necrosis factor therapy in psoriatic arthritis. Arthritis Care & Research. 67: 842-7. PMID 25469741 DOI: 10.1002/Acr.22529 |
0.506 |
|
| 2015 |
Eder L, Chandran V, Gladman DD. What have we learned about genetic susceptibility in psoriasis and psoriatic arthritis? Current Opinion in Rheumatology. 27: 91-8. PMID 25415529 DOI: 10.1097/Bor.0000000000000136 |
0.603 |
|
| 2015 |
Pollock RA, Abji F, Liang K, Chandran V, Pellett FJ, Virtanen C, Gladman DD. Gene expression differences between psoriasis patients with and without inflammatory arthritis. The Journal of Investigative Dermatology. 135: 620-3. PMID 25243786 DOI: 10.1038/Jid.2014.414 |
0.506 |
|
| 2015 |
Das S, Stuart PE, Ding J, Tejasvi T, Li Y, Tsoi LC, Chandran V, Fischer J, Helms C, Duffin KC, Voorhees JJ, Bowcock AM, Krueger GG, Lathrop GM, Nair RP, et al. Fine mapping of eight psoriasis susceptibility loci. European Journal of Human Genetics : Ejhg. 23: 844-53. PMID 25182136 DOI: 10.1038/Ejhg.2014.172 |
0.414 |
|
| 2015 |
Eder L, Thavaneswaran A, Chandran V, Cook R, Gladman DD. Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients. Arthritis Care & Research. 67: 264-72. PMID 25047020 DOI: 10.1002/Acr.22401 |
0.684 |
|
| 2015 |
Eder L, Thavaneswaran A, Chandran V, Cook RJ, Gladman DD. Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis. Annals of the Rheumatic Diseases. 74: 813-7. PMID 24431392 DOI: 10.1136/Annrheumdis-2013-204448 |
0.648 |
|
| 2015 |
Pollock R, O'Rielly D, Dohey A, Codner D, Chandran V, Gladman D, Rahman P. THU0006 Validation of Differential Methylation in Maternally Versus Paternally Transmitted Psoriatic Disease Annals of the Rheumatic Diseases. 74: 195.1-195. DOI: 10.1136/Annrheumdis-2015-Eular.5891 |
0.525 |
|
| 2015 |
Eder L, Abji F, Rosen C, Chandran V, Gladman D. HLA-Class I genes are associated with a higher burden of atherosclerosis in patients with psoriatic disease Atherosclerosis. 241: e53. DOI: 10.1016/J.Atherosclerosis.2015.04.187 |
0.667 |
|
| 2014 |
Maharaj AB, Chandran V. Unusual cause of limited elbow movement in a patient with psoriatic arthritis. The Journal of Rheumatology. 41: 2482-3. PMID 25452180 DOI: 10.3899/Jrheum.140870 |
0.376 |
|
| 2014 |
Haddad A, Thavaneswaran A, Abji F, Pellett F, Chandran V, Wither JE, Gladman DD. Immunoglobulin G subclass analysis in psoriatic arthritis. The Journal of Rheumatology. 41: 2421-4. PMID 25320220 DOI: 10.3899/Jrheum.131477 |
0.474 |
|
| 2014 |
Chandran V, Scher JU. Biomarkers in psoriatic arthritis: recent progress. Current Rheumatology Reports. 16: 453. PMID 25218735 DOI: 10.1007/S11926-014-0453-4 |
0.433 |
|
| 2014 |
Asiri A, Thavaneswaran A, Kalman-Lamb G, Chandran V, Gladman DD. The effectiveness of leflunomide in psoriatic arthritis. Clinical and Experimental Rheumatology. 32: 728-31. PMID 25151858 |
0.389 |
|
| 2014 |
Okada Y, Han B, Tsoi LC, Stuart PE, Ellinghaus E, Tejasvi T, Chandran V, Pellett F, Pollock R, Bowcock AM, Krueger GG, Weichenthal M, Voorhees JJ, Rahman P, Gregersen PK, et al. Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes. American Journal of Human Genetics. 95: 162-72. PMID 25087609 DOI: 10.1016/J.Ajhg.2014.07.002 |
0.457 |
|
| 2014 |
Helliwell P, Coates L, Chandran V, Gladman D, de Wit M, FitzGerald O, Kavanaugh A, Strand V, Mease PJ, Boehncke WH, Langley RG, Lubrano E, Maccarone M, Schulze-Koops H, Miceli-Richard C, et al. Qualifying unmet needs and improving standards of care in psoriatic arthritis. Arthritis Care & Research. 66: 1759-66. PMID 25047391 DOI: 10.1002/Acr.22404 |
0.516 |
|
| 2014 |
FitzGerald O, Mease PJ, Helliwell PS, Chandran V. GRAPPA 2013 Annual Meeting, rheumatology updates: psoriatic arthritis (PsA) biomarker project, arthritis mutilans, PsA-peripheral spondyloarthritis epidemiology project. The Journal of Rheumatology. 41: 1244-8. PMID 24882863 DOI: 10.3899/Jrheum.140181 |
0.428 |
|
| 2014 |
Gladman DD, Abufayyah M, Abuffayah M, Salonen D, Thavaneswaran A, Chandran V. Radiological characteristics of the calcaneal spurs in psoriatic arthritis. Clinical and Experimental Rheumatology. 32: 401-3. PMID 24850064 |
0.393 |
|
| 2014 |
Eder L, Thavaneswaran A, Chandran V, Cook R, Gladman DD. Increased burden of inflammation over time is associated with the extent of atherosclerotic plaques in patients with psoriatic arthritis. Annals of the Rheumatic Diseases. PMID 24827532 DOI: 10.1136/Annrheumdis-2014-205267 |
0.686 |
|
| 2014 |
Sheane BJ, Chandran V. Investigational drugs for treating psoriatic arthritis. Expert Opinion On Investigational Drugs. 23: 1001-16. PMID 24758276 DOI: 10.1517/13543784.2014.910194 |
0.41 |
|
| 2014 |
Kennedy M, Papneja A, Thavaneswaran A, Chandran V, Gladman DD. Prevalence and predictors of reduced work productivity in patients with psoriatic arthritis. Clinical and Experimental Rheumatology. 32: 342-8. PMID 24708934 |
0.445 |
|
| 2014 |
Wong NW, Ng VY, Ibrahim S, Slessarev M, Chandran V. Lupus - the cold, hard facts. Lupus. 23: 837-9. PMID 24699313 DOI: 10.1177/0961203314530485 |
0.314 |
|
| 2014 |
McDonough E, Ayearst R, Eder L, Chandran V, Rosen CF, Thavaneswaran A, Gladman DD. Depression and anxiety in psoriatic disease: prevalence and associated factors. The Journal of Rheumatology. 41: 887-96. PMID 24692521 DOI: 10.3899/Jrheum.130797 |
0.62 |
|
| 2014 |
Biagioni BJ, Gladman DD, Cook RJ, Eder L, Wakhlu A, Shen H, Chandran V. Reliability of radiographic scoring methods in axial psoriatic arthritis. Arthritis Care & Research. 66: 1417-22. PMID 24515627 DOI: 10.1002/Acr.22308 |
0.62 |
|
| 2014 |
Eder L, Jayakar J, Thavaneswaran A, Haddad A, Chandran V, Salonen D, Rosen CF, Gladman DD. Is the MAdrid Sonographic Enthesitis Index useful for differentiating psoriatic arthritis from psoriasis alone and healthy controls? The Journal of Rheumatology. 41: 466-72. PMID 24488414 DOI: 10.3899/Jrheum.130949 |
0.683 |
|
| 2014 |
Chandran V, Bull SB, Pellett FJ, Ayearst R, Pollock RA, Gladman DD. Killer-cell immunoglobulin-like receptor gene polymorphisms and susceptibility to psoriatic arthritis. Rheumatology (Oxford, England). 53: 233-9. PMID 24185760 DOI: 10.1093/Rheumatology/Ket296 |
0.474 |
|
| 2014 |
Eder L, Chandran V, Gladman DD. The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease. Annals of the Rheumatic Diseases. 73: 1990-6. PMID 23887287 DOI: 10.1136/Annrheumdis-2013-203433 |
0.65 |
|
| 2014 |
Eder L, Thavaneswaran A, Chandran V, Gladman DD. Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis. Annals of the Rheumatic Diseases. 73: 1007-11. PMID 23619157 DOI: 10.1136/Annrheumdis-2012-202959 |
0.681 |
|
| 2014 |
Sheane BJ, Chandran V. The future of treatment for psoriatic arthritis International Journal of Clinical Rheumatology. 9: 59-71. DOI: 10.2217/Ijr.13.69 |
0.432 |
|
| 2014 |
O'Rielly D, Pollock R, Zhang Y, Al-Ghanim N, Yazdani R, Hamilton S, Bricknell R, Chandran V, Ardern R, Gladman D, Zhai G, Rahman P. AB0160 Epigenetic Studies in Maternally versus Paternally Transmitted Psoriatic Disease Annals of the Rheumatic Diseases. 73: 856.1-856. DOI: 10.1136/Annrheumdis-2014-Eular.3309 |
0.437 |
|
| 2014 |
Gladman DD, Chandran V. Management of psoriatic arthritis Rheumatology: Sixth Edition. 2: 1008-1013. DOI: 10.1016/B978-0-323-09138-1.00122-4 |
0.336 |
|
| 2013 |
Chandran V, Bull SB, Pellett FJ, Ayearst R, Rahman P, Gladman DD. Human leukocyte antigen alleles and susceptibility to psoriatic arthritis. Human Immunology. 74: 1333-8. PMID 23916976 DOI: 10.1016/J.Humimm.2013.07.014 |
0.43 |
|
| 2013 |
Chandran V, Gladman DD, Helliwell PS, Gudbjörnsson B. Arthritis mutilans: a report from the GRAPPA 2012 annual meeting. The Journal of Rheumatology. 40: 1419-22. PMID 23908536 DOI: 10.3899/Jrheum.130453 |
0.527 |
|
| 2013 |
Gladman DD, Ziouzina O, Thavaneswaran A, Chandran V. Dactylitis in psoriatic arthritis: prevalence and response to therapy in the biologic era. The Journal of Rheumatology. 40: 1357-9. PMID 23818708 DOI: 10.3899/Jrheum.130163 |
0.526 |
|
| 2013 |
Haddad A, Thavaneswaran A, Toloza S, Chandran V, Gladman DD. Diffuse idiopathic skeletal hyperostosis in psoriatic arthritis. The Journal of Rheumatology. 40: 1367-73. PMID 23772085 DOI: 10.3899/Jrheum.121433 |
0.565 |
|
| 2013 |
Husted JA, Thavaneswaran A, Chandran V, Gladman DD. Incremental effects of comorbidity on quality of life in patients with psoriatic arthritis. The Journal of Rheumatology. 40: 1349-56. PMID 23772076 DOI: 10.3899/Jrheum.121500 |
0.491 |
|
| 2013 |
Cretu D, Diamandis EP, Chandran V. Delineating the synovial fluid proteome: recent advancements and ongoing challenges in biomarker research. Critical Reviews in Clinical Laboratory Sciences. 50: 51-63. PMID 23758541 DOI: 10.3109/10408363.2013.802408 |
0.348 |
|
| 2013 |
Chandran V, Shen H, Pollock RA, Pellett FJ, Carty A, Cook RJ, Gladman DD. Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis. The Journal of Rheumatology. 40: 866-71. PMID 23637322 DOI: 10.3899/Jrheum.121162 |
0.514 |
|
| 2013 |
Pollock RA, Chandran V, Pellett FJ, Thavaneswaran A, Eder L, Barrett J, Rahman P, Farewell V, Gladman DD. The functional MICA-129 polymorphism is associated with skin but not joint manifestations of psoriatic disease independently of HLA-B and HLA-C. Tissue Antigens. 82: 43-7. PMID 23611695 DOI: 10.1111/Tan.12126 |
0.649 |
|
| 2013 |
Haddad A, Chandran V. Arthritis mutilans. Current Rheumatology Reports. 15: 321. PMID 23430715 DOI: 10.1007/s11926-013-0321-7 |
0.329 |
|
| 2013 |
Chaudhry SR, Thavaneswaran A, Chandran V, Gladman DD. Physician scores vs patient self-report of joint and skin manifestations in psoriatic arthritis. Rheumatology (Oxford, England). 52: 705-11. PMID 23267168 DOI: 10.1093/Rheumatology/Kes355 |
0.554 |
|
| 2013 |
Eder L, Jayakar J, Pollock R, Pellett F, Thavaneswaran A, Chandran V, Rosen CF, Gladman DD. Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity. Annals of the Rheumatic Diseases. 72: 1956-61. PMID 23243196 DOI: 10.1136/Annrheumdis-2012-202325 |
0.659 |
|
| 2013 |
Eissa A, Cretu D, Soosaipillai A, Thavaneswaran A, Pellett F, Diamandis A, Cevikbas F, Steinhoff M, Diamandis EP, Gladman D, Chandran V. Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease. Clinical Chemistry and Laboratory Medicine. 51: 317-25. PMID 23096109 DOI: 10.1515/Cclm-2012-0251 |
0.561 |
|
| 2013 |
Eder L, Jayakar J, Shanmugarajah S, Thavaneswaran A, Pereira D, Chandran V, Rosen CF, Gladman DD. The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone. Annals of the Rheumatic Diseases. 72: 715-20. PMID 22736087 DOI: 10.1136/Annrheumdis-2012-201497 |
0.705 |
|
| 2013 |
Eder L, Thavaneswaran A, Chandran V, Gladman DD. Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis. Annals of the Rheumatic Diseases. 72: 578-82. PMID 22589379 DOI: 10.1136/Annrheumdis-2012-201357 |
0.633 |
|
| 2013 |
Chandran V. The genetics of psoriasis and psoriatic arthritis. Clinical Reviews in Allergy & Immunology. 44: 149-56. PMID 22274791 DOI: 10.1007/S12016-012-8303-5 |
0.338 |
|
| 2013 |
Touma Z, Thavaneswaran A, Chandran V, Gladman DD. SAT0308 Responsiveness of Patient Reported Outcomes to Biological Treatment in Psoriatic Arthritis Annals of the Rheumatic Diseases. 72: A688.1-A688. DOI: 10.1136/Annrheumdis-2013-Eular.2033 |
0.503 |
|
| 2013 |
Eder L, Thavaneswaran A, Chandran V, Cook R, Gladman DD. SAT0288 Male Gender is Associated with Accelerated Radiographic Progression in Axial Damage but not with Progression of Peripheral Damage Annals of the Rheumatic Diseases. 72: A681.1-A681. DOI: 10.1136/Annrheumdis-2013-Eular.2013 |
0.661 |
|
| 2013 |
Haddad A, Thavaneswaran A, Arruza IR, Chandran V, Cook R, Gladman D. SAT0273 The Characteristics and Predictors of Minimal Disease Activity in Patients with Psoriatic Arthritis on TNF Blockers Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.1998 |
0.586 |
|
| 2013 |
Toloza S, Vega-Hinojosa O, Chandran V, Valle-Oñate R, Espinoza L. SAT0312 Psoriasis and psoriatic arthritis among natives and mestizos from the andean mountains region of peru Annals of the Rheumatic Diseases. 71: 577.3-578. DOI: 10.1136/Annrheumdis-2012-Eular.3259 |
0.443 |
|
| 2013 |
Coates LC, Chandran V. Outcome assessment in psoriatic arthritis Indian Journal of Rheumatology. 8. DOI: 10.1016/J.Injr.2013.11.007 |
0.392 |
|
| 2013 |
Chandran V. Psoriatic arthritis: How to diagnosis it early? Indian Journal of Rheumatology. 8: 117-121. DOI: 10.1016/J.Injr.2013.07.001 |
0.378 |
|
| 2012 |
Tsoi LC, Spain SL, Knight J, Ellinghaus E, Stuart PE, Capon F, Ding J, Li Y, Tejasvi T, Gudjonsson JE, Kang HM, Allen MH, McManus R, Novelli G, Samuelsson L, ... ... Chandran V, et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nature Genetics. 44: 1341-8. PMID 23143594 DOI: 10.1038/Ng.2467 |
0.442 |
|
| 2012 |
Gladman DD, Chandran V, Thavaneswaran A, Zummer M. Psoriatic arthritis in Canadian clinical practice: the PsA assessment in rheumatology. The Journal of Rheumatology. 39: 1850-3. PMID 22859361 DOI: 10.3899/Jrheum.120282 |
0.59 |
|
| 2012 |
Chandran V. Spondyloarthritis: CASPAR criteria in early psoriatic arthritis. Nature Reviews. Rheumatology. 8: 503-4. PMID 22825727 DOI: 10.1038/Nrrheum.2012.121 |
0.417 |
|
| 2012 |
Chandran V. Soluble biomarkers may differentiate psoriasis from psoriatic arthritis. The Journal of Rheumatology. Supplement. 89: 65-6. PMID 22751596 DOI: 10.3899/Jrheum.120247 |
0.405 |
|
| 2012 |
Eder L, Chandran V, Pellett F, Shanmugarajah S, Rosen CF, Bull SB, Gladman DD. Differential human leucocyte allele association between psoriasis and psoriatic arthritis: a family-based association study. Annals of the Rheumatic Diseases. 71: 1361-5. PMID 22586163 DOI: 10.1136/Annrheumdis-2012-201308 |
0.636 |
|
| 2012 |
Haddad A, Chandran V. How can psoriatic arthritis be diagnosed early? Current Rheumatology Reports. 14: 358-63. PMID 22576859 DOI: 10.1007/S11926-012-0262-6 |
0.422 |
|
| 2012 |
Rosenbaum J, Chandran V. Management of comorbidities in ankylosing spondylitis. The American Journal of the Medical Sciences. 343: 364-6. PMID 22543539 DOI: 10.1097/Maj.0B013E3182514059 |
0.304 |
|
| 2012 |
Jordan CT, Cao L, Roberson ED, Duan S, Helms CA, Nair RP, Duffin KC, Stuart PE, Goldgar D, Hayashi G, Olfson EH, Feng BJ, Pullinger CR, Kane JP, Wise CA, ... ... Chandran V, et al. Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis. American Journal of Human Genetics. 90: 796-808. PMID 22521419 DOI: 10.1016/J.Ajhg.2012.03.013 |
0.429 |
|
| 2012 |
Touma Z, Thavaneswaran A, Chandran V, Gladman DD. Does the change in season affect disease activity in patients with psoriatic arthritis? Annals of the Rheumatic Diseases. 71: 1370-3. PMID 22504562 DOI: 10.1136/Annrheumdis-2011-201208 |
0.556 |
|
| 2012 |
Fitzgerald O, Chandran V. Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. The Journal of Rheumatology. 39: 427-30. PMID 22298273 DOI: 10.3899/Jrheum.111241 |
0.331 |
|
| 2012 |
Rosen CF, Mussani F, Chandran V, Eder L, Thavaneswaran A, Gladman DD. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. Rheumatology (Oxford, England). 51: 571-6. PMID 22157469 DOI: 10.1093/Rheumatology/Ker365 |
0.66 |
|
| 2012 |
Tejasvi T, Stuart PE, Chandran V, Voorhees JJ, Gladman DD, Rahman P, Elder JT, Nair RP. TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis. The Journal of Investigative Dermatology. 132: 593-600. PMID 22113471 DOI: 10.1038/Jid.2011.376 |
0.481 |
|
| 2012 |
Eder L, Shanmugarajah S, Thavaneswaran A, Chandran V, Rosen CF, Cook RJ, Gladman DD. The association between smoking and the development of psoriatic arthritis among psoriasis patients. Annals of the Rheumatic Diseases. 71: 219-24. PMID 21953342 DOI: 10.1136/Ard.2010.147793 |
0.619 |
|
| 2012 |
Eder L, Chandran V, Pellet F, Shanmugarajah S, Rosen CF, Bull SB, Gladman DD. Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis. Annals of the Rheumatic Diseases. 71: 50-5. PMID 21900282 DOI: 10.1136/Ard.2011.155044 |
0.624 |
|
| 2012 |
Eder L, Chandran V, Gladman DD. Dr. Eder, et al, reply Journal of Rheumatology. 39: 186. DOI: 10.3899/Jrheum.110828 |
0.535 |
|
| 2012 |
Eder L, Chandran V, Gladman DD. Gender-related differences in patients with psoriatic arthritis International Journal of Clinical Rheumatology. 7: 641-649. DOI: 10.2217/Ijr.12.63 |
0.632 |
|
| 2012 |
Gladman DD, Thavaneswaran A, Chandran V. Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? (Annals of the Rheumatic Diseases (2011) 70, (2152-2154)) Annals of the Rheumatic Diseases. 71: 1592. DOI: 10.1136/ard.2011.150938corr1 |
0.469 |
|
| 2011 |
Touma Z, Eder L, Zisman D, Feld J, Chandran V, Rosen CF, Shen H, Cook RJ, Gladman DD. Seasonal variation in vitamin D levels in psoriatic arthritis patients from different latitudes and its association with clinical outcomes. Arthritis Care & Research. 63: 1440-7. PMID 22121512 DOI: 10.1002/Acr.20530 |
0.615 |
|
| 2011 |
MacKenzie H, Thavaneswaran A, Chandran V, Gladman DD. Patient-reported outcome in psoriatic arthritis: a comparison of Web-based versus paper-completed questionnaires. The Journal of Rheumatology. 38: 2619-24. PMID 22045844 DOI: 10.3899/Jrheum.110165 |
0.525 |
|
| 2011 |
Gladman DD, Thavaneswaran A, Chandran V, Cook RJ. Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? Annals of the Rheumatic Diseases. 70: 2152-4. PMID 21914627 DOI: 10.1136/Ard.2011.150938 |
0.557 |
|
| 2011 |
Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, Gladman DD. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care & Research. 63: 1729-35. PMID 21905258 DOI: 10.1002/Acr.20627 |
0.707 |
|
| 2011 |
Pollock RA, Pellett FJ, Chandran V, Gladman DD. Expression patterns of natural killer receptor genes in inflamed joints and peripheral blood of patients with psoriatic arthritis. Tissue Antigens. 78: 345-7. PMID 21883096 DOI: 10.1111/J.1399-0039.2011.01764.X |
0.465 |
|
| 2011 |
Eder L, Chandran V, Pellett F, Pollock R, Shanmugarajah S, Rosen CF, Rahman P, Gladman DD. IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients. Annals of the Rheumatic Diseases. 70: 1594-8. PMID 21613309 DOI: 10.1136/Ard.2010.147421 |
0.608 |
|
| 2011 |
Eder L, Law T, Chandran V, Shanmugarajah S, Shen H, Rosen CF, Cook RJ, Gladman DD. Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care & Research. 63: 1091-7. PMID 21560259 DOI: 10.1002/Acr.20496 |
0.634 |
|
| 2011 |
Gladman DD, Chandran V. Review of clinical registries of psoriatic arthritis: lessons learned?: value for the future? Current Rheumatology Reports. 13: 346-52. PMID 21494786 DOI: 10.1007/S11926-011-0182-X |
0.564 |
|
| 2011 |
Pollock R, Chandran V, Barrett J, Eder L, Pellett F, Yao C, Lino M, Shanmugarajah S, Farewell VT, Gladman DD. Differential major histocompatibility complex class I chain-related A allele associations with skin and joint manifestations of psoriatic disease. Tissue Antigens. 77: 554-61. PMID 21457151 DOI: 10.1111/J.1399-0039.2011.01670.X |
0.663 |
|
| 2011 |
Eder L, Chandran V, Shen H, Cook RJ, Shanmugarajah S, Rosen CF, Gladman DD. Incidence of arthritis in a prospective cohort of psoriasis patients. Arthritis Care & Research. 63: 619-22. PMID 21452273 DOI: 10.1002/Acr.20401 |
0.686 |
|
| 2011 |
Boehncke WH, Gladman DD, Chandran V. Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting. The Journal of Rheumatology. 38: 567-71. PMID 21362790 DOI: 10.3899/Jrheum.101124 |
0.574 |
|
| 2011 |
Chandran V, Gladman DD. Toronto Psoriatic Arthritis Screening (ToPAS) questionnaire: a report from the GRAPPA 2009 annual meeting. The Journal of Rheumatology. 38: 546-7. PMID 21362783 DOI: 10.3899/Jrheum.101117 |
0.465 |
|
| 2011 |
Eder L, Chandran V, Gladman DD. Repair of radiographic joint damage following treatment with etanercept in psoriatic arthritis is demonstrable by 3 radiographic methods. The Journal of Rheumatology. 38: 1066-70. PMID 21324963 DOI: 10.3899/Jrheum.100919 |
0.636 |
|
| 2011 |
Touma Z, Urowitz MB, Fortin PR, Landolt C, Toloza SM, Riddell C, Chandran V, Eder L, Ghanem A, Ziouzina O, Taghavi-Zadeh S, Ibañez D, Gladman DD. Systemic lupus erythematosus disease activity index 2000 responder index-50: a reliable index for measuring improvement in disease activity. The Journal of Rheumatology. 38: 868-73. PMID 21324961 DOI: 10.3899/Jrheum.101080 |
0.645 |
|
| 2011 |
Cresswell L, Chandran V, Farewell VT, Gladman DD. Inflammation in an individual joint predicts damage to that joint in psoriatic arthritis. Annals of the Rheumatic Diseases. 70: 305-8. PMID 20980703 DOI: 10.1136/Ard.2010.135087 |
0.531 |
|
| 2011 |
Gladman DD, Chandran V. Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology (Oxford, England). 50: 25-31. PMID 20693260 DOI: 10.1093/Rheumatology/Keq262 |
0.534 |
|
| 2011 |
Evans DM, Reveille JD, Brown M, Chandran V, Gladman DD, Martin TM, McGovern D, Wordsworth P, Inman RD. The genetic basis of spondyloarthritis: SPARTAN/IGAS 2009 (Journal of Rheumatology (2010) 37 (2626-2631)) Journal of Rheumatology. 38: 788. DOI: 10.3899/Jrheum.100892C1 |
0.38 |
|
| 2011 |
Gladman DD, Chandran V. Standardizing the monitoring of outcome measures: Imaging in psoriatic arthritis International Journal of Clinical Rheumatology. 6: 77-86. DOI: 10.2217/Ijr.10.103 |
0.517 |
|
| 2010 |
Evans DM, Reveille JD, Brown MA, Chandran V, Gladman DD, Martin TM, McGovern D, Wordsworth P, Inman RD. The genetic basis of spondyloarthritis: SPARTAN/IGAS 2009. The Journal of Rheumatology. 37: 2626-31. PMID 21123336 DOI: 10.3899/Jrheum.100892 |
0.446 |
|
| 2010 |
Weisman M, Learch TJ, Baraliakos X, Chandran V, Gladman DD, Raychaudhuri SP, Xu H, Collantes-Estévez E, Vázquez-Mellado J, Mease PJ, Sieper J, Deodhar AA, Colbert RA, Clegg DO. Current controversies in spondyloarthritis: SPARTAN. The Journal of Rheumatology. 37: 2617-23. PMID 21123334 DOI: 10.3899/Jrheum.100890 |
0.44 |
|
| 2010 |
Chandran V, Rahman P. Update on the genetics of spondyloarthritis--ankylosing spondylitis and psoriatic arthritis. Best Practice & Research. Clinical Rheumatology. 24: 579-88. PMID 21035081 DOI: 10.1016/J.Berh.2010.05.006 |
0.334 |
|
| 2010 |
Eder L, Chandran V, Shen H, Cook RJ, Gladman DD. Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis? Annals of the Rheumatic Diseases. 69: 2160-4. PMID 20627946 DOI: 10.1136/Ard.2010.129726 |
0.661 |
|
| 2010 |
Chandran V. Genetics of psoriasis and psoriatic arthritis. Indian Journal of Dermatology. 55: 151-6. PMID 20606885 DOI: 10.4103/0019-5154.62751 |
0.313 |
|
| 2010 |
Chandran V, Siannis F, Rahman P, Pellett FJ, Farewell VT, Gladman DD. Folate pathway enzyme gene polymorphisms and the efficacy and toxicity of methotrexate in psoriatic arthritis. The Journal of Rheumatology. 37: 1508-12. PMID 20472929 DOI: 10.3899/Jrheum.091311 |
0.482 |
|
| 2010 |
Chandran V, Gladman DD. Update on biomarkers in psoriatic arthritis. Current Rheumatology Reports. 12: 288-94. PMID 20437120 DOI: 10.1007/S11926-010-0107-0 |
0.536 |
|
| 2010 |
Chandran V, Cook RJ, Edwin J, Shen H, Pellett FJ, Shanmugarajah S, Rosen CF, Gladman DD. Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. Rheumatology (Oxford, England). 49: 1399-405. PMID 20421218 DOI: 10.1093/Rheumatology/Keq105 |
0.536 |
|
| 2010 |
Eder L, Chandran V, Ueng J, Bhella S, Lee KA, Rahman P, Pope A, Cook RJ, Gladman DD. Predictors of response to intra-articular steroid injection in psoriatic arthritis. Rheumatology (Oxford, England). 49: 1367-73. PMID 20388640 DOI: 10.1093/Rheumatology/Keq102 |
0.619 |
|
| 2010 |
Eder L, Chandran V, Schentag CT, Shen H, Cook RJ, Gladman DD. Time and predictors of response to tumour necrosis factor-alpha blockers in psoriatic arthritis: an analysis of a longitudinal observational cohort. Rheumatology (Oxford, England). 49: 1361-6. PMID 20385615 DOI: 10.1093/Rheumatology/Keq091 |
0.642 |
|
| 2010 |
Chandran V, Tolusso DC, Cook RJ, Gladman DD. Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis. The Journal of Rheumatology. 37: 809-15. PMID 20231209 DOI: 10.3899/Jrheum.091059 |
0.566 |
|
| 2010 |
Coates LC, Cook R, Lee KA, Chandran V, Gladman DD. Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort. Arthritis Care & Research. 62: 970-6. PMID 20191569 DOI: 10.1002/Acr.20162 |
0.529 |
|
| 2010 |
Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. Journal of Autoimmunity. 34: J314-21. PMID 20034760 DOI: 10.1016/J.Jaut.2009.12.001 |
0.38 |
|
| 2009 |
Chandran V, Barrett J, Schentag CT, Farewell VT, Gladman DD. Axial psoriatic arthritis: update on a longterm prospective study. The Journal of Rheumatology. 36: 2744-50. PMID 19884276 DOI: 10.3899/Jrheum.090412 |
0.504 |
|
| 2009 |
Eder L, Chandran V, Gladman DD. From ankylosis to pencil-in-cup deformity in psoriatic arthritis: A case report Clinical and Experimental Rheumatology. 27: 661-663. PMID 19772803 |
0.603 |
|
| 2009 |
Chandran V, Gottlieb A, Cook RJ, Duffin KC, Garg A, Helliwell P, Kavanaugh A, Krueger GG, Langley RG, Lynde C, McHugh N, Mease P, Olivieri I, Rahman P, Rosen CF, et al. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis and Rheumatism. 61: 1235-42. PMID 19714610 DOI: 10.1002/Art.24562 |
0.55 |
|
| 2009 |
Chandran V. Epidemiology of psoriatic arthritis. The Journal of Rheumatology. 36: 213-5. PMID 19208553 DOI: 10.3899/Jrheum.081242 |
0.379 |
|
| 2009 |
Toloza S, Pellett F, Chandran V, Ibanez D, Urowitz M, Gladman D. Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus. Lupus. 17: 793-8. PMID 18755860 DOI: 10.1177/0961203308089443 |
0.469 |
|
| 2009 |
Chandran V, Schentag CT, Brockbank JE, Pellett FJ, Shanmugarajah S, Toloza SM, Rahman P, Gladman DD. Familial aggregation of psoriatic arthritis. Annals of the Rheumatic Diseases. 68: 664-7. PMID 18524791 DOI: 10.1136/Ard.2008.089367 |
0.532 |
|
| 2009 |
Gladman DD, Schentag CT, Tom BD, Chandran V, Brockbank J, Rosen C, Farewell VT. Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Annals of the Rheumatic Diseases. 68: 497-501. PMID 18445625 DOI: 10.1136/Ard.2008.089441 |
0.437 |
|
| 2009 |
Pollock RA, Pellett FJ, Chandran V, Gladman D. 240-P: Killer cell immunoglobulin-like receptor gene expression in inflamed joints of patients with psoriatic arthritis (PsA) Human Immunology. 70: S133. DOI: 10.1016/J.Humimm.2009.09.273 |
0.493 |
|
| 2009 |
Pellett F, Chandran V, Rahman P, Gladman D. 154-P: Activating KIRs in siblings of patients with psoriatic arthritis Human Immunology. 70: S88. DOI: 10.1016/J.Humimm.2009.09.187 |
0.518 |
|
| 2008 |
Chandran V, Schentag CT, Gladman DD. Sensitivity and specificity of the CASPAR criteria for psoriatic arthritis in a family medicine clinic setting. The Journal of Rheumatology. 35: 2069-70; author repl. PMID 18843760 |
0.343 |
|
| 2008 |
Duffin KC, Chandran V, Gladman DD, Krueger GG, Elder JT, Rahman P. Genetics of psoriasis and psoriatic arthritis: update and future direction. The Journal of Rheumatology. 35: 1449-53. PMID 18609743 |
0.441 |
|
| 2008 |
Chandran V, Schentag CT, Gladman DD. Reappraisal of the effectiveness of methotrexate in psoriatic arthritis: results from a longitudinal observational cohort. The Journal of Rheumatology. 35: 469-71. PMID 18085735 |
0.479 |
|
| 2007 |
Chandran V, O'Shea FD, Schentag CT, Inman RD, Gladman DD. Relationship between spinal mobility and radiographic damage in ankylosing spondylitis and psoriatic spondylitis: a comparative analysis. The Journal of Rheumatology. 34: 2463-5. PMID 18050375 |
0.361 |
|
| 2007 |
Chandran V, Schentag CT, Gladman DD. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis and Rheumatism. 57: 1560-3. PMID 18050230 DOI: 10.1002/Art.23104 |
0.486 |
|
| 2007 |
Chandran V, Pellett F, Gladman DD. Killer cell immunoglobulin-like receptor gene's repertoire in rheumatoid arthritis [6] Scandinavian Journal of Rheumatology. 36: 409. PMID 17963178 DOI: 10.1080/03009740701406601 |
0.434 |
|
| 2007 |
Gladman DD, Inman RD, Cook RJ, Maksymowych WP, Braun J, Davis JC, Landewé RB, Mease P, Brandt J, Vargas RB, Chandran V, Helliwell P, Kavanaugh A, O'Shea FD, Khan MA, et al. International spondyloarthritis interobserver reliability exercise--the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis. The Journal of Rheumatology. 34: 1740-5. PMID 17659754 |
0.488 |
|
| 2007 |
Gladman DD, Inman RD, Cook RJ, van der Heijde D, Landewé RB, Braun J, Davis JC, Mease P, Brandt J, Vargas RB, Chandran V, Helliwell P, Kavanaugh A, O'Shea FD, Khan MA, et al. International spondyloarthritis interobserver reliability exercise--the INSPIRE study: I. Assessment of spinal measures. The Journal of Rheumatology. 34: 1733-9. PMID 17611985 |
0.438 |
|
| 2007 |
Chandran V, Bhella S, Schentag C, Gladman DD. Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis. Annals of the Rheumatic Diseases. 66: 936-9. PMID 17324972 DOI: 10.1136/Ard.2006.065763 |
0.501 |
|
| 2007 |
Pellett FJ, Chandran V, Rahman P, Gladman DD. 92-P: KIR haplotypes in psoriatic arthritis families Human Immunology. 68: S61. DOI: 10.1016/J.Humimm.2007.08.115 |
0.429 |
|
| 2007 |
Pellett FJ, Chandran V, Martin MP, Carrington M, Gladman DD. 84-P: Unusual KIR haplotypes in patients with psoriatic arthritis and their family members Human Immunology. 68: S57. DOI: 10.1016/J.Humimm.2007.08.107 |
0.473 |
|
| 2006 |
Chandran V, Upadhyaya SK, Haroon N, Aggarwal A, Misra R. Lack of clinical association with antibodies to ribosomal P proteins in Indian patients with systemic lupus erythematosus. The Journal of Rheumatology. 33: 1987-9. PMID 17014015 DOI: 10.1016/S0973-3698(10)60232-4 |
0.344 |
|
| 2005 |
Chandran V, Aggarwal A, Misra R. Active disease during pregnancy is associated with poor foetal outcome in Indian patients with systemic lupus erythematosus Rheumatology International. 26: 152-156. PMID 15627198 DOI: 10.1007/S00296-004-0540-3 |
0.305 |
|
| Show low-probability matches. |